Product Number |
ARP37992_T100 |
Product Page |
www.avivasysbio.com/rfx5-antibody-n-terminal-region-arp37992-t100.html |
Name |
RFX5 Antibody - N-terminal region (ARP37992_T100) |
Protein Size (# AA) |
616 amino acids |
Molecular Weight |
68kDa |
NCBI Gene Id |
5993 |
Host |
Rabbit |
Clonality |
Polyclonal |
Concentration |
1.0 mg/ml |
Gene Full Name |
Regulatory factor X, 5 (influences HLA class II expression) |
Peptide Sequence |
Synthetic peptide located within the following region: MAEDEPDAKSPKTGGRAPPGGAEAGEPTTLLQRLRGTISKAVQNKVEGIL |
Product Format |
Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose. |
Reference |
Nagarajan,U.M., (2004) J. Immunol. 173 (1), 410-419 |
Description of Target |
RFX5 is the fifth member of the growing family of DNA-binding proteins sharing a novel and highly characteristic DNA-binding domain called the RFX motif. RFX is a nuclear protein complex that binds to the X box of MHC-II promoters. The lack of RFX binding activity in complementation group C results from mutations in the RFX5 gene encoding the 75-kD subunit of RFX.A lack of MHC-II expression results in a severe immunodeficiency syndrome called MHC-II deficiency, or the bare lymphocyte syndrome (BLS; MIM 209920). At least 4 complementation groups have been identified in B-cell lines established from patients with BLS. The molecular defects in complementation groups B, C, and D all lead to a deficiency in RFX.A lack of MHC-II expression results in a severe immunodeficiency syndrome called MHC-II deficiency, or the bare lymphocyte syndrome (BLS; MIM 209920). At least 4 complementation groups have been identified in B-cell lines established from patients with BLS. The molecular defects in complementation groups B, C, and D all lead to a deficiency in RFX, a nuclear protein complex that binds to the X box of MHC-II promoters. The lack of RFX binding activity in complementation group C results from mutations in the RFX5 gene encoding the 75-kD subunit of RFX (Steimle et al., 1995). RFX5 is the fifth member of the growing family of DNA-binding proteins sharing a novel and highly characteristic DNA-binding domain called the RFX motif. Multiple alternatively spliced transcript variants have been found but the full-length natures of only two have been determined. |
Protein Interactions |
UBC; MRPL53; SLIRP; SRPRB; CDV3; LSM7; RPS19; RBMS1; NDUFA7; NDUFA2; ANKRA2; RFXANK; MLLT1; HDAC4; CIITA; HDAC2; RFXAP; |
Reconstitution and Storage |
For short term use, store at 2-8C up to 1 week. For long term storage, store at -20C in small aliquots to prevent freeze-thaw cycles. |
Datasheets/Manuals |
Printable datasheet for anti-RFX5 (ARP37992_T100) antibody |
Blocking Peptide |
For anti-RFX5 (ARP37992_T100) antibody is Catalog # AAP37992 (Previous Catalog # AAPP20094) |
Immunogen |
The immunogen is a synthetic peptide directed towards the N terminal region of human RFX5 |
Uniprot ID |
P48382 |
Protein Name |
DNA-binding protein RFX5 |
Protein Accession # |
NP_001020774 |
Purification |
Protein A purified |
Nucleotide Accession # |
NM_001025603 |
Tested Species Reactivity |
Human |
Gene Symbol |
RFX5 |
Predicted Species Reactivity |
Human, Rat, Dog, Guinea Pig, Horse, Pig, Rabbit |
Application |
WB |
Predicted Homology Based on Immunogen Sequence |
Dog: 86%; Guinea Pig: 79%; Horse: 86%; Human: 100%; Pig: 86%; Rabbit: 86%; Rat: 79% |
Image 1 | Transfected 293T
| WB Suggested Anti-RFX5 Antibody Titration: 2.5ug/ml ELISA Titer: 1:1562500 Positive Control: Transfected 293T |
|
|